File: Script_2.wav
WER: 2.50%
Total Errors: 2

Original Ground Truth:
Psoriasis
Methotrexate A folate antagonist DMARD  Disease-Modifying Antirheumatic Drug, a systemic therapy
Clobetasol Propionate A potent topical corticosteroid for psoriatic plaques
Calcipotriol A vitamin D analogue used topically
Cyclosporine A calcineurin inhibitor used for severe, recalcitrant psoriasis
Apremilast An oral PDE4 inhibitor
Secukinumab Ixekizumab Biologics, specifically Interleukin-17A inhibitors
Weight Loss
Orlistat A pancreatic lipase inhibitor, reduces dietary fat absorption
Metformin Often used off-label for weight management in patients with insulin resistance
Liraglutide A GLP-1 receptor agonist approved for obesity management

Normalized Ground Truth:
psoriasis methotrexate a folate antagonist dmard diseasemodifying antirheumatic drug a systemic therapy clobetasol propionate a potent topical corticosteroid for psoriatic plaques calcipotriol a vitamin d analogue used topically cyclosporine a calcineurin inhibitor used for severe recalcitrant psoriasis apremilast an oral pde4 inhibitor secukinumab ixekizumab biologics specifically interleukin17a inhibitors weight loss orlistat a pancreatic lipase inhibitor reduces dietary fat absorption metformin often used offlabel for weight management in patients with insulin resistance liraglutide a glp1 receptor agonist approved for obesity management

Raw Transcription:
Psoriasis. Methotrexate, a folate antagonist, DMARDs, disease-modifying antirheumatic drug, a systemic therapy. Clobetasol propionate, potent topical corticosteroid for psoriatic plaques. Calcipotriol, a vitamin D analogue used topically. Cyclosporine, a calcineurin inhibitor used for severe recalcitrant psoriasis. Apremilast, an oral PDE4 inhibitor. Secukinumab, ixekizumab, biologics, specifically interleukin-17A inhibitors. Weight loss. Orlistat, a pancreatic lipase inhibitor, reduces dietary fat absorption. Metformin often used off-label for weight management in patients with insulin resistance. Liraglutide, a GLP-1 receptor agonist, approved for obesity management.

Normalized Transcription:
psoriasis methotrexate a folate antagonist dmards diseasemodifying antirheumatic drug a systemic therapy clobetasol propionate potent topical corticosteroid for psoriatic plaques calcipotriol a vitamin d analogue used topically cyclosporine a calcineurin inhibitor used for severe recalcitrant psoriasis apremilast an oral pde4 inhibitor secukinumab ixekizumab biologics specifically interleukin17a inhibitors weight loss orlistat a pancreatic lipase inhibitor reduces dietary fat absorption metformin often used offlabel for weight management in patients with insulin resistance liraglutide a glp1 receptor agonist approved for obesity management

Detailed Errors:
1. Substitution: 'dmard' -> 'dmards'
2. Deletion: 'a' -> '---'
